J. Green

Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolones.

P. Traxler, J. Green, H. Mett, 1999, Journal of medicinal chemistry.

A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo.

M. Šuša, J. Green, J. Feyen, 1999, Bone.

7-Alkyl- and 7-cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines--potent inhibitors of the tyrosine kinase c-Src.

E. Altmann, M. Šuša, J. Green, 2001, Bioorganic & medicinal chemistry letters.

Suramin analogues protect cartilage against osteoarthritic breakdown by increasing levels of tissue inhibitor of metalloproteinases 3 (TIMP-3) in the tissue.

S. Wren, J. Green, M. Piras, 2023, Bioorganic & medicinal chemistry.

7-Pyrrolidinyl- and 7-piperidinyl-5-aryl-pyrrolo[2,3-d]pyrimidines--potent inhibitors of the tyrosine kinase c-Src.

E. Altmann, M. Šuša, J. Green, 2001, Bioorganic & medicinal chemistry letters.

Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-Src.

E. Altmann, M. Šuša, J. Green, 2000, Bioorganic & medicinal chemistry letters.